க்கு சிகிச்சை மற்றும் குணப்படுத்துதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from க்கு சிகிச்சை மற்றும் குணப்படுத்துதல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In க்கு சிகிச்சை மற்றும் குணப்படுத்துதல் Today - Breaking & Trending Today

Halberd Corporation: Halberd Antibodies Shown To Be Effective Against Multiple Covid-19 Mutations


Halberd Corporation: Halberd Antibodies Shown To Be Effective Against Multiple Covid-19 Mutations
JACKSON CENTER, PA / ACCESSWIRE / April 21, 2021 / Halberd Corporation s (OTC PINK:HALB) two patent-pending monoclonal antibodies have demonstrated strong affinity and neutralizing capabilities against three of the identified SARS-CoV-2 mutations. The principal researcher, Dr. Shawn Chen, indicated that Halberd s two monoclonal antibodies have been successfully tested against the Q498Y, P499T and Q493K SARS-2 variants. Mouse testing is planned to confirm the laboratory tests and is scheduled to start as soon as the certified disease-free laboratory mice are secured.
William A. Hartman, Chairman, President & CEO of Halberd Corporation, said, It is very exciting to realize that our antibodies against the Covid-19 Spike Protein are also effective against several of the current global Covid-19 mutations. We believe that Halberd s antibodies could be the solution for select Covid- ....

Shawn Chen , Kostenloser Wertpapierhandel , Williama Hartman , William Hinman , Jay Clayton , Division Of Corporation , Halberd Corporation , Cytokine Storm , For Treating And Curing , Private Securities Litigation Reform Act , Corporation Finance , Self Regulatory Organizations , ஷான் சென் , வில்லியம் ஹுீன்மந் , ஜெய் களிமண் , பிரிவு ஆஃப் நிறுவனம் , க்கு சிகிச்சை மற்றும் குணப்படுத்துதல் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , நிறுவனம் நிதி , சுய ஒழுங்குமுறை ஆர்கநைஸேஶந்ஸ் ,

Epidemiologic Solutions Corporation (ESC), an IRS Approved, Qualified Public Charity, Announces Its Funding for Its Pain-Free-Veterans Initiative


(0)
Westlake, Louisiana (Newsfile Corp. - April 14, 2021) - Epidemiologic Solutions Corporation (ESC), a public charity qualified by the Internal Revenue Service pursuant to Section 501(c)(3) commits not less than $200,000 of funding to Gold River Productions Services (OTC Pink: GRPS) for its development of Painplex
TM an all-herbal extraction developed by Gold River Productions Services (GRPS) and other formulations. This will be part of the Relief Kit which will include products from both GRPS and Halberd Corporation (OTC Pink: HALB) designed to alleviate moderate to severe discomfort without opioids or other potentially harmful and addictive drug. The kit and products will be available free of charge to veterans in need. Such veterans will be encouraged to provide feedback about Relief Kit . ....

William Hartman , Richard Goulding , Kostenloser Wertpapierhandel , Williama Hartman , William Hinman , Bruce Bond , Jay Clayton , Revenue Service , Division Of Corporation , Epidemiologic Solutions Corporation , Louisiana Newsfile Corp , Gold River Productions Inc , Gold River Productions Services , Products Development , Halberd Corporation , Epidemiologic Solutions , Solutions Corporation , Internal Revenue Service , Gold River Productions , Chief Products Development , Internal Revenue Code Sections , Driver Productions , Cytokine Storm , For Treating And Curing , Private Securities Litigation Reform Act , Corporation Finance ,

Halberd Corporation CEO Letter


Halberd Corporation CEO Letter
JACKSON CENTER, PA / ACCESSWIRE / April 6, 2021 /
Greetings From The CEO And Staff At
HALBERD
(OTC PINK:HALB)
It has been a very busy and fruitful first quarter of 2021. Often, people get so wrapped up in the day-to-day events that we lose sight of just how far we have traveled. So, it is worthwhile to stop every so often and measure our progress.
STOCK PERFORMANCE
One year ago, Halberd re-invented itself and began assembling a management and scientific team to address the needs and challenges posed by SARS-CoV-2. At that time, Halberd s stock was trading at $0.0004/share.
At the close of 2020, Halberd was trading at $0.025/share, a 6,250% increase. ....

Kostenloser Wertpapierhandel , Williama Hartman , William Hinman , Jay Clayton , Division Of Corporation , Youngstown State University , Epidemiologic Solutions Corporation , Halberd Corporation , Staff At , Radio Frequency , Youngstown State , Cytokine Storm , For Treating And Curing , Private Securities Litigation Reform Act , Corporation Finance , Self Regulatory Organizations , வில்லியம் ஹுீன்மந் , ஜெய் களிமண் , பிரிவு ஆஃப் நிறுவனம் , யங்ஸ்டவுன் நிலை பல்கலைக்கழகம் , ஊழியர்கள் இல் , வானொலி அதிர்வெண் , யங்ஸ்டவுன் நிலை , க்கு சிகிச்சை மற்றும் குணப்படுத்துதல் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , நிறுவனம் நிதி ,

Halberd Corporation Starts VITA-SHIELD-MAX Immunity Boosting Nutraceutical Production


Halberd Corporation Starts VITA-SHIELD-MAX Immunity Boosting Nutraceutical Production
JACKSON CENTER, PA / ACCESSWIRE / March 16, 2021 / Halberd Corporation (OTC PINK:HALB) has contracted with a major nutraceutical manufacturer to produce its initial production lot of Halberd s VITA-SHIELD-MAX
TM Immune Booster. Halberd s scientists designed this proprietary combination of vitamins and minerals to help the body increase its natural immunity and promote general health.
Dr. Patricio Reyes, Halberd Corporation s Chief Technical Officer, indicated, Halberd s formulation was not arrived at lightly. After much research and discussions with medical professionals here and abroad, this combination of ingredients was selected to provide significant immune boosting capability.
William A. Hartman, Chairman, President & CEO of Halberd Corp., stated, This initial production will be used along with a booklet of third party medical articles supporting our selection of ingredien ....

Patricio Reyes , Kostenloser Wertpapierhandel , Williama Hartman , William Hinman , Jay Clayton , Halberd Corp , Division Of Corporation , Halberd Corporation , Chief Technical Officer , Cytokine Storm , For Treating And Curing , Private Securities Litigation Reform Act , Corporation Finance , Self Regulatory Organizations , பேட்ரிஸியோ ரெய்ஸ் , வில்லியம் ஹுீன்மந் , ஜெய் களிமண் , பிரிவு ஆஃப் நிறுவனம் , தலைமை தொழில்நுட்ப அதிகாரி , க்கு சிகிச்சை மற்றும் குணப்படுத்துதல் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , நிறுவனம் நிதி , சுய ஒழுங்குமுறை ஆர்கநைஸேஶந்ஸ் ,